News & Features / Current News

FDA approves new ovarian cancer drug

Opening a new chapter in the use of genomic science to fight cancer, the Food and Drug Administration on Friday approved olaparib, a medication for advanced ovarian cancer associated with a defective BRCA gene.

The new drug, to be marketed under ...